Daniel M. Skovronsky is based out of Indianapolis, Indiana and is the Chief Scientific and Product Officer and President of Eli Lilly. Daniel previously worked at Avid Radiopharmaceuticals as a Founder. Daniel M. Skovronsky attended the University of Pennsylvania and Yale University. Daniel M. Skovronsky has been received the honor in Time Magazine 100 Most Influential people in health, Honorary Doctorate of Medicine from Oakland University, and the Melvin R. Goodes Prize by the Alzheimer’s Drug Discovery Foundation in their career. Daniel M. Skovronsky has been named as the 2025 Kavli Oxford Lecture Award recipient by the University of Oxford (United Kingdom), Cleveland Clinic #1 Innovation of 2011 (for amyloid imaging), the 2021 Roy VagelosPro Bono Humanum Award (for COVID19 antibody), and the Galien Foundation 2023 Best Pharmaceutical Product Prix Galien (for tirzepatide) in their career.